Kenneth J Pienta (Ken Pienta, K J Pienta, Kenneth Pienta, Kenneth C Valkenburg)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 54

Top Topics

Benign Prostatic Hyperplasia

Radical Prostatectomy

Top Venues

Medical oncology (Northwood, London, England)

Prostate cancer and prostatic diseases

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Christopher Carroll, Auraya Manaprasertsak, Arthur Boffelli Castro, Hilda van den Bos, Diana Carolina Johanna Spierings, Rene Wardenaar, Anuraag Bukkuri, Niklas Engström, Etienne Baratchart, Minjun Yang, Andrea Biloglav, Charlie Kinahan Cornwallis, Bertil Johansson, Catharina Hagerling, Marie Arsenian Henriksson, Kajsa Paulsson, Sarah R Amend, Sofie Mohlin, Floris Foijer, Alan McIntyre, Kenneth J Pienta, Emma U Hammarlund
Drug-resilient Cancer Cell Phenotype Is Acquired via Polyploidization Associated with Early Stress Response Coupled to HIF2α Transcriptional Regulation. Cancer research communications 4 (3) (2024)
Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Christopher Carroll, Auraya Manaprasertsak, Arthur Boffelli Castro, Hilda van den Bos, Diana Carolina Johanna Spierings, Rene Wardenaar, Anuraag Bukkuri, Niklas Engström, Etienne Baratchart, Minjun Yang, Andrea Biloglav, Charlie Kinahan Cornwallis, Bertil Johansson, Catharina Hagerling, Marie Arsenian Henriksson, Kajsa Paulsson, Sarah R Amend, Sofie Mohlin, Floris Foijer, Alan McIntyre, Kenneth J Pienta, Emma U Hammarlund
Drug-resilient cancer cell phenotype is acquired via polyploidization associated with early stress response coupled to HIF-2α transcriptional regulation. Cancer research communications (2024)
Christopher Carroll, Auraya Manaprasertsak, Arthur Boffelli Castro, Hilda van den Bos, Diana Carolina Johanna Spierings, Rene Wardenaar, Anuraag Bukkuri, Niklas Engström, Etienne Baratchart, Minjun Yang, Andrea Biloglav, Charlie Kinahan Cornwallis, Bertil Johansson, Catharina Hagerling, Marie Arsenian Henriksson, Kajsa Paulsson, Sarah R Amend, Sofie Mohlin, Floris Foijer, Alan McIntyre, Kenneth J Pienta, Emma U Hammarlund
Drug-resilient Cancer Cell Phenotype Is Acquired via Polyploidization Associated with Early Stress Response Coupled to HIF2α Transcriptional Regulation. Cancer research communications 4 (3) (2024)
Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Christopher Carroll, Auraya Manaprasertsak, Arthur Boffelli Castro, Hilda van den Bos, Diana Carolina Johanna Spierings, Rene Wardenaar, Anuraag Bukkuri, Niklas Engström, Etienne Baratchart, Minjun Yang, Andrea Biloglav, Charlie Kinahan Cornwallis, Bertil Johansson, Catharina Hagerling, Marie Arsenian Henriksson, Kajsa Paulsson, Sarah R Amend, Sofie Mohlin, Floris Foijer, Alan McIntyre, Kenneth J Pienta, Emma U Hammarlund
Drug-resilient Cancer Cell Phenotype Is Acquired via Polyploidization Associated with Early Stress Response Coupled to HIF2α Transcriptional Regulation. Cancer research communications 4 (3) (2024)
Wanyoung Lim, Inwoo Hwang, Jiande Zhang, Zhenzhong Chen, Jeonghun Han, Jaehyung Jeon, Bon-Kyoung Koo, Sangmin Kim, Jeong Eon Lee, Youngkwan Kim, Kenneth J Pienta, Sarah R Amend, Robert H Austin, Jee-Yin Ahn, Sungsu Park
Exploration of drug resistance mechanisms in triple negative breast cancer cells using a microfluidic device and patient tissues. eLife 12 (2024)
Judd W Moul, Neal D Shore, Kenneth J Pienta, Johannes Czernin, Martin T King, Stephen J Freedland
Correction: Application of next-generation imaging in biochemically recurrent prostate cancer. Prostate cancer and prostatic diseases (2024)
Christopher Carroll, Auraya Manaprasertsak, Arthur Boffelli Castro, Hilda van den Bos, Diana Carolina Johanna Spierings, Rene Wardenaar, Anuraag Bukkuri, Niklas Engström, Etienne Baratchart, Minjun Yang, Andrea Biloglav, Charlie Kinahan Cornwallis, Bertil Johansson, Catharina Hagerling, Marie Arsenian Henriksson, Kajsa Paulsson, Sarah R Amend, Sofie Mohlin, Floris Foijer, Alan McIntyre, Kenneth J Pienta, Emma U Hammarlund
Drug-resilient Cancer Cell Phenotype Is Acquired via Polyploidization Associated with Early Stress Response Coupled to HIF2α Transcriptional Regulation. Cancer research communications 4 (3) (2024)
Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Wanyoung Lim, Inwoo Hwang, Jiande Zhang, Zhenzhong Chen, Jeonghun Han, Jaehyung Jeon, Bon-Kyoung Koo, Sangmin Kim, Jeong Eon Lee, Youngkwan Kim, Kenneth J Pienta, Sarah R Amend, Robert H Austin, Jee-Yin Ahn, Sungsu Park
Exploration of drug resistance mechanisms in triple negative breast cancer cells using a microfluidic device and patient tissues. eLife 12 (2024)
Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Liang Dong, Cong Hu, Zehua Ma, Yiyao Huang, Greg Shelley, Morgan D Kuczler, Chi-Ju Kim, Kenneth W Witwer, Evan T Keller, Sarah R Amend, Wei Xue, Kenneth J Pienta
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England) 41 (7) (2024)
Richard C Zieren, Patricia J Zondervan, Kenneth J Pienta, Axel Bex, Theo M de Reijke, Adriaan D Bins
Diagnostic liquid biopsy biomarkers in renal cell cancer. Nature reviews. Urology (2023)
Neal D Shore, Judd W Moul, Kenneth J Pienta, Johannes Czernin, Martin T King, Stephen J Freedland
Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification. Prostate cancer and prostatic diseases (2023)
Eugene Shenderov, Angelo M DeMarzo, Tamara L Lotan, Hao Wang, Sin Chan, Su Jin Lim, Hongkai Ji, Mohamad E Allaf, Carolyn Chapman, Paul A Moore, Francine Chen, Kristina Sorg, Andrew M White, Sarah E Church, Briana Hudson, Paul A Fields, Shaohui Hu, Samuel R Denmeade, Kenneth J Pienta, Christian P Pavlovich, Ashley E Ross, Charles G Drake, Drew M Pardoll, Emmanuel S Antonarakis
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial. Nature medicine (2023)
Lisa Welter, Serena Zheng, Sonia Maryam Setayesh, Michael Morikado, Arushi Agrawal, Rafael Nevarez, Amin Naghdloo, Milind Pore, Nikki Higa, Anand Kolatkar, Jana-Aletta Thiele, Priyanka Sharma, Halle C F Moore, Jennifer K Richer, Anthony Elias, Kenneth J Pienta, Amado J Zurita, Mitchell E Gross, Stephanie N Shishido, James B Hicks, Carmen Ruiz Velasco, Peter Kuhn
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics. Cancers 15 (15) (2023)
Judd W Moul, Neal D Shore, Kenneth J Pienta, Johannes Czernin, Martin T King, Stephen J Freedland
Application of next-generation imaging in biochemically recurrent prostate cancer. Prostate cancer and prostatic diseases (2023)
Joel S Brown, Sarah R Amend, Robert H Austin, Robert A Gatenby, Emma U Hammarlund, Kenneth J Pienta
Updating the definition of cancer. Molecular cancer research : MCR (2023)
Peng Huang, Peter B Illei, Wilbur Franklin, Pei-Hsun Wu, Patrick M Forde, Saeed Ashrafinia, Chen Hu, Hamza Khan, Harshna V Vadvala, Ie-Ming Shih, Richard J Battafarano, Michael A Jacobs, Xiangrong Kong, Justine Lewis, Rongkai Yan, Yun Chen, Franck Housseau, Arman Rahmim, Elliot K Fishman, David S Ettinger, Kenneth J Pienta, Denis Wirtz, Malcolm V Brock, Stephen Lam, Edward Gabrielson
Lung Cancer Recurrence Risk Prediction through Integrated Deep Learning Evaluation. Cancers 14 (17) (2022)
Luke V Loftus, Sarah R Amend, Kenneth J Pienta
Interplay between Cell Death and Cell Proliferation Reveals New Strategies for Cancer Therapy. International journal of molecular sciences 23 (9) (2022)
Andrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala, Jeremie Calais, Lucia Nappi, Ravi B Parikh, Tyler M Seibert, Elizabeth V Wasmuth, Xiao X Wei, Kenneth J Pienta, Howard R Soule
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting. The Prostate (2022)
Florian Jacques, Etienne Baratchart, Kenneth J Pienta, Emma U Hammarlund
Origin and evolution of animal multicellularity in the light of phylogenomics and cancer genetics. Medical oncology (Northwood, London, England) 39 (11) (2022)
Gao Wang, Trung V Phan, Shengkai Li, Jing Wang, Yan Peng, Guo Chen, Junle Qu, Daniel I Goldman, Simon Asher Levin, Kenneth J Pienta, Sarah R Amend, Robert H Austin, Liyu Liu
Robots as models of evolving systems. Proceedings of the National Academy of Sciences of the United States of America 119 (12) (2022)
Samikshan Dutta, Navatha Shree Polavaram, Ridwan Islam, Sreyashi Bhattacharya, Sanika Bodas, Thomas Mayr, Sohini Roy, Sophie Alvarez Y Albala, Marieta I Toma, Anza Darehshouri, Angelika Borkowetz, Stefanie Conrad, Susanne Fuessel, Manfred Wirth, Gustavo B Baretton, Lorenz C Hofbauer, Paramita Ghosh, Kenneth J Pienta, David L Klinkebiel, Surinder Kumar Batra, Michael H Muders, Kaustubh Datta
Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer. Oncogene 41 (30) (2022)
Tushar R Garg, Rudolf A Werner, Hyun Woo Chung, Wajahat Khatri, Kenneth J Pienta, Martin G Pomper, Michael A Gorin, Elie Saad, Steven P Rowe
Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on 18 F-DCFPyL PET/CT Scans. Tomography (Ann Arbor, Mich.) 8 (6) (2022)
Matthew P Deek, Kim Van der Eecken, Philip Sutera, Rebecca A Deek, Valérie Fonteyne, Adrianna A Mendes, Karel Decaestecker, Ana Ponce Kiess, Nicolaas Lumen, Ryan Phillips, Aurélie De Bruycker, Mark Mishra, Zaker Rana, Jason K Molitoris, Bieke Lambert, Louke Delrue, Hailun Wang, Kathryn Lowe, Sofie L J Verbeke, Jo Van Dorpe, Renée Bultijnck, Geert Villeirs, Kathia De Man, Filip Ameye, Daniel Y Song, Theodore DeWeese, Channing J Paller, Felix Y Feng, Alexander W Wyatt, Kenneth J Pienta, Maximillian Diehn, Soren M Bentzen, Steven Joniau, Friedl Vanhaverbeke, Gert De Meerleer, Emmanuel S Antonarakis, Tamara L Lotan, Alejandro Berlin, Shankar Siva, Piet Ost, Phuoc T Tran
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Philip Sutera, Kim Van Der Eecken, Amar U Kishan, Anis Hamid, Emily Grist, Gerhardt Attard, Tamara Lotan, Adrianna A Mendes, Channing J Paller, Michael A Carducci, Ashley Evan Ross, Hao Wang, Kenneth J Pienta, Felix Y Feng, Emmanuel S Antonarakis, Piet Ost, Daniel Y Song, Stephen Greco, Curtiland Deville, Theodore DeWeese, Phuoc T Tran, Matthew P Deek
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics. Prostate cancer and prostatic diseases 25 (4) (2022)
Rajendra Kumar, Janet Mendonca, Olutosin Owoyemi, Kavya Boyapati, Naiju Thomas, Suthicha Kanacharoen, Max Coffey, Deven Topiwala, Carolina Gomes, Busra Ozbek, Tracy Jones, Marc Rosen, Liang Dong, Sadie Wiens, W Nathaniel Brennen, John T Isaacs, Angelo M DeMarzo, Mark C Markowski, Emmanuel S Antonarakis, David Z Qian, Kenneth J Pienta, Drew M Pardoll, Michael A Carducci, Samuel R Denmeade, Sushant K Kachhap
Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer. Cancer research 81 (23) (2021)
Amber E de Groot, Kayla V Myers Chen, Timothy E G Krueger, Ashley L Kiemen, Natalia H Nagy, Alexandria Brame, Vicente E Torres, Zhongyuan Zhang, Levent Trabzonlu, W Nathaniel Brennen, Denis Wirtz, Angelo M De Marzo, Sarah R Amend, Kenneth J Pienta
Characterization of tumor-associated macrophages in prostate cancer transgenic mouse models. The Prostate 81 (10) (2021)
Kenneth J Pienta, E U Hammarlund, J S Brown, Sarah R Amend, Robert Axelrod
Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells. Proceedings of the National Academy of Sciences of the United States of America 118 (7) (2021)
Tanina Arab, Emily R Mallick, Yiyao Huang, Liang Dong, Zhaohao Liao, Zezhou Zhao, Olesia A Gololobova, Barbara Smith, Norman J Haughey, Kenneth J Pienta, Barbara S Slusher, Patrick M Tarwater, Juan Pablo Tosar, Angela M Zivkovic, Wyatt N Vreeland, Michael E Paulaitis, Kennith W Witwer
Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single-particle analysis platforms. Journal of extracellular vesicles 10 (6) (2021)
Diane K Reyes, Kenneth J Pienta
Peripheral androgen blockade in men with castrate-sensitive biochemical recurrent prostate cancer. Medical oncology (Northwood, London, England) 38 (7) (2021)
Jillian N Eskra, Daniel Rabizadeh, Leslie Mangold, Elizabeth Fabian, W Nathaniel Brennen, David B Yeater, Kenneth J Pienta, Alan W Partin, William B Isaacs, Christian P Pavlovich, Jun Luo
A novel method for detection of exfoliated prostate cancer cells in urine by RNA in situ hybridization. Prostate cancer and prostatic diseases 24 (1) (2020)
Emma U Hammarlund, Sarah R Amend, Kenneth J Pienta
The issues with tissues: the wide range of cell fate separation enables the evolution of multicellularity and cancer. Medical oncology (Northwood, London, England) 37 (7) (2020)
Sara Sheikhbahaei, Diane K Reyes, Steven P Rowe, Kenneth J Pienta
CT-based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration-naïve oligometastatic prostate cancer. The Prostate 81 (2) (2020)
Andrea K Miyahira, Kenneth J Pienta, John W Babich, Neil H Bander, Jeremie Calais, Peter Choyke, Michael S Hofman, Steven M Larson, Frank I Lin, Michael J Morris, Martin G Pomper, Shahneen Sandhu, Howard I Scher, Scott T Tagawa, Scott G Williams, Howard R Soule
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting. The Prostate 80 (15) (2020)
Steven N Quayle, Natasha Girgis, Dharma R Thapa, Zohra Merazga, Melissa M Kemp, Alex Histed, Fan Zhao, Miguel Moreta, Paige Ruthardt, Sandrine Hulot, Alyssa Nelson, Lauren D Kraemer, Dominic R Beal, Luke Witt, Jessica Ryabin, Jonathan Soriano, Mark Haydock, Emily Spaulding, John F Ross, Peter A Kiener, Steven Almo, Rodolfo Chaparro, Ronald Seidel, Anish Suri, Saso Cemerski, Kenneth J Pienta, Mary Ellen Simcox
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (8) (2020)
Kenneth J Pienta, Emma U Hammarlund, Robert Axelrod, Sarah R Amend, Joel S Brown
Convergent Evolution, Evolving Evolvability, and the Origins of Lethal Cancer. Molecular cancer research : MCR 18 (6) (2020)
Andrea K Miyahira, Adam Sharp, Leigh Ellis, Jennifer Jones, Salma Kaochar, H Benjamin Larman, David A Quigley, Huihui Ye, Jonathan W Simons, Kenneth J Pienta, Howard R Soule
Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting. The Prostate 80 (2) (2019)
Emma E van der Toom, Haley D Axelrod, Jean J de la Rosette, Theo M de Reijke, Kenneth J Pienta, Kenneth C Valkenburg
Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies. Nature reviews. Urology 16 (1) (2019)
Jinlu Dai, June Escara-Wilke, Jill M Keller, Younghun Jung, Russell S Taichman, Kenneth J Pienta, Evan T Keller
Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis. The Journal of experimental medicine 216 (12) (2019)
Marco Archetti, Kenneth J Pienta
Cooperation among cancer cells: applying game theory to cancer. Nature reviews. Cancer 19 (2) (2019)
Kenneth C Valkenburg, Amber E de Groot, Kenneth J Pienta
Targeting the tumour stroma to improve cancer therapy. Nature reviews. Clinical oncology 15 (6) (2019)
Andrea K Miyahira, Kenneth J Pienta, Michael J Morris, Neil H Bander, Richard P Baum, Wolfgang P Fendler, William Goeckeler, Michael A Gorin, Hartwig Hennekes, Martin G Pomper, Oliver Sartor, Scott T Tagawa, Scott Williams, Howard R Soule
Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group. The Prostate 78 (11) (2018)
Haley D Axelrod, Kenneth J Pienta, Sarah R Amend, Jessica L Hicks, Princy Parsana, Gonzalo Torga, Angelo M DeMarzo
AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer. Molecular cancer research : MCR 17 (2) (2018)
Karen S Sfanos, Mark C Markowski, Lauren B Peiffer, Sarah E Ernst, James R White, Kenneth J Pienta, Emmanuel S Antonarakis, Ashley E Ross
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate cancer and prostatic diseases 21 (4) (2018)